View Older Stories View More Recent Stories

Jul 3, 2025 09:24AM Legend Biotech Corp. (LEGN) PT Lowered to $54 at UBS
Jul 2, 2025 06:38AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Jul 1, 2025 06:00AM BMO lists 3 top biotech ideas for H2
Jun 3, 2025 10:45AM Legend Biotech (LEGN) Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
Jun 2, 2025 07:03AM RBC Capital: 'Legend Biotech Corp. (LEGN) Still Undervalued'
Jun 2, 2025 05:08AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
May 22, 2025 05:25PM Legend Biotech (LEGN) announces new data evaluating CARVYKTI
May 16, 2025 10:32AM RBC Capital on Legend Biotech Corp. (LEGN): 'We See A Compelling Valuation'
May 14, 2025 01:56AM Legend Biotech (LEGN) Misses Q1 EPS by 6c
May 13, 2025 04:38PM TD Cowen Reiterates Buy Rating on Legend Biotech Corp. (LEGN), PT $62, 'We Like The Profile At These Levels'
May 13, 2025 04:00PM Legend Biotech Corp. (LEGN) PT Lowered to $71 at Truist Securities
May 13, 2025 03:26PM Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Apr 11, 2025 09:44AM Piper Sandler: 'What Biotech Names to Own in Market Volatility'
Apr 10, 2025 10:07AM TD Cowen on Legend Biotech Corp. (LEGN): 'Carvykti Should Beat in Q1, Easing Investor Concerns'
Apr 8, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Mar 12, 2025 10:56AM RBC Capital on Legend Biotech Corp. (LEGN): 'See An Attractive Entrypoint With Strong 2025 Growth Potential'
Mar 12, 2025 10:18AM BMO Capital Reiterates Outperform on Legend Biotech Corp. (LEGN), Sees 'Upside in 2025'
Mar 12, 2025 09:25AM Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
Mar 12, 2025 06:39AM Legend Biotech Corp. (LEGN) PT Raised to $75 at H.C. Wainwright
Mar 11, 2025 04:57PM Legend Biotech (LEGN) Tops Q4 EPS by 9c
Jan 22, 2025 12:27PM Legend Biotech Corp. (LEGN) PT Lowered to $91 at Jefferies
Jan 22, 2025 11:11AM Goldman Sachs Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Jan 21, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Jan 10, 2025 12:33PM Legend Biotech (LEGN) Strength Tied to Unconfirmed Chatter
Dec 30, 2024 11:36AM Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
Dec 22, 2024 04:00AM Barclays shares outlook for Biotech in 2025, names preferred stocks
Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025
Dec 20, 2024 12:46PM BMO Capital Highlights Favorite Names for 2025 in Biotech
Dec 16, 2024 07:03AM RBC Capital's Global Biotech Outlook Report: 'Top 2025 Ideas'
Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside
Nov 15, 2024 10:52AM Legend Biotech (LEGN) option IV flat as share price near low end of two-year range
Nov 13, 2024 07:21AM Legend Biotech Corp. (LEGN) PT Raised to $83 at Cantor Fitzgerald
Nov 4, 2024 07:32AM Legend Biotech (LEGN) Appoints Alan Bash as President of CARVYKTI
Oct 16, 2024 07:45AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Oct 16, 2024 06:54AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Oct 15, 2024 03:22PM BTIG Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Oct 15, 2024 02:15PM Barclays Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
Oct 11, 2024 08:47AM TD Cowen Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Oct 9, 2024 07:28AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Oct 8, 2024 04:12AM Redburn-Atlantic Starts Legend Biotech Corp. (LEGN) at Buy
Oct 4, 2024 06:36AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Sep 30, 2024 12:18PM Scotiabank Reiterates Sector Outperform Rating on Legend Biotech Corp. (LEGN)
Sep 30, 2024 08:27AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Sep 30, 2024 07:54AM Piper Sandler Reiterates Overweight Rating on Legend Biotech Corp. (LEGN)
Sep 30, 2024 07:23AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Aug 28, 2024 06:40AM H.C. Wainwright Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
Aug 12, 2024 12:43PM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Aug 9, 2024 07:21AM Legend Biotech (LEGN) Tops Q2 EPS by 24c
Aug 8, 2024 04:09PM Legend Biotech (LEGN) Appoints Peter Salovey to its Board
View More Recent Stories View Older Stories